
Before PathogenDx, Milan Patel built cars, ran an electronics company, learned finance at Intel and watched his first startup fail. His third venture turns tiny patterns on glass into same-shift answers for laboratories - a career assembled from engineering, money and the nerve to ship.
PathogenDx spent years turning a three-dimensional DNA microarray into a commercial test. Cannabis labs supplied the opening; poultry processors may supply the scale.